Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial.
Lundby Christensen L, Almdal T, Boesgaard T, Breum L, Dunn E, Gade-Rasmussen B, Gluud C, Hedetoft C, Jarloev A, Jensen T, Krarup T, Johansen LB, Lund SS, Madsbad S, Mathiesen E, Moelvig J, Nielsen F, Perrild H, Pedersen O, Roeder M, Sneppen SB, Snorgaard O, Tarnow L, Thorsteinsson B, Vaag A, Vestergaard H, Wetterslev J, Wiinberg N; CIMT Trial Group. Lundby Christensen L, et al. Among authors: wetterslev j. Diabetes Obes Metab. 2009 Apr;11(4):315-22. doi: 10.1111/j.1463-1326.2008.00959.x. Diabetes Obes Metab. 2009. PMID: 19267709 Clinical Trial.
[Reporting adverse reactions and events in randomised clinical trials].
Hemmingsen B, Støy L, Wetterslev J, Tarnow L, Friis KB, Christensen LL, Sales N, Gluud C; Copenhagen Insulin Metformin Therapy Trial-Gruppen. Hemmingsen B, et al. Among authors: wetterslev j. Ugeskr Laeger. 2010 Aug 30;172(35):2381-4. Ugeskr Laeger. 2010. PMID: 20825743 Danish.
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J. Hemmingsen B, et al. Among authors: wetterslev j. Cochrane Database Syst Rev. 2011 Jun 15;(6):CD008143. doi: 10.1002/14651858.CD008143.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2013 Nov 11;(11):CD008143. doi: 10.1002/14651858.CD008143.pub3 PMID: 21678374 Updated. Review.
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T. Hemmingsen B, et al. Among authors: wetterslev j. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009008. doi: 10.1002/14651858.CD009008.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2015 Jul 29;(7):CD009008. doi: 10.1002/14651858.CD009008.pub3 PMID: 23633364 Updated. Review.
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Hemmingsen C, Wetterslev J. Hemmingsen B, et al. Among authors: wetterslev j. Cochrane Database Syst Rev. 2013 Nov 11;(11):CD008143. doi: 10.1002/14651858.CD008143.pub3. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2015 Jul 29;(7):CD008143. doi: 10.1002/14651858.CD008143.pub4 PMID: 24214280 Updated. Review.
348 results